Citations: Impact of selective platelet inhibition in reducing cardiovascular risk

Views

CrossRef citations to date

Altmetric

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Robert Goggs & Alex M. Lynch. 2022. Schalm's Veterinary Hematology. Schalm's Veterinary Hematology 855 864 .

Tommi Tervonen, Thibaud Prawitz, Gin Nie Chua, Johanna Hyacinthe & Cathy Anne Pinto. (2022) Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment. Journal of Clinical Epidemiology 144, pages 84-92.
Crossref

E. V. Slukhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. G. Solopova, V. N. Galkin, A. S. Shkoda, V. I. Tsibizova, V. I. Linnikov, Ismail Elalamy, J.-С. Gris, B. Brenner & A. D. Makatsariya. (2021) Platelets, thrombo-inflammation and cancer. Obstetrics, Gynecology and Reproduction 15:6, pages 755-776.
Crossref

Attila Braun, Hans-Joachim Anders, Thomas Gudermann & Elmina Mammadova-Bach. (2021) Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues. Frontiers in Oncology 11.
Crossref

Carolin LangnauAnne-Katrin Rohlfing, Sarah GekelerManina GünterSimone PöschelÁlvaro Petersen-UribePhilippa JaegerAlban AvdiuTobias HarmKlaus-Peter KreisselmeierTatsiana CastorTamam BakchoulDominik RathMeinrad Paul Gawaz, Stella E. Autenrieth & Karin Anne Lydia Mueller. (2021) Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19. Arteriosclerosis, Thrombosis, and Vascular Biology 41:6, pages 2080-2096.
Crossref

Maciej Bladowski, Jakub Gawrys, Damian Gajecki, Ewa Szahidewicz-Krupska, Anna Sawicz-Bladowska & Adrian Doroszko. (2020) Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside. Oxidative Medicine and Cellular Longevity 2020, pages 1-18.
Crossref

AbhijitS Nair. (2017) Vorapaxar: The missing link in antiplatelet therapy!. Journal of Anaesthesiology Clinical Pharmacology 33:2, pages 269.
Crossref

Impact of selective platelet inhibition in reducing cardiovascular risk – role of vorapaxar

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of selective platelet inhibition in reducing cardiovascular risk – role of vorapaxar

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date